Literature DB >> 23662902

A redox economical synthesis of bioactive 6,12-guaianolides.

Bo Wen1, Joseph K Hexum, John C Widen, Daniel A Harki, Kay M Brummond.   

Abstract

Syntheses of two 6,12-guaianolide analogs are reported within. The scope of the tandem allylboration/lactonization chemistry is expanded to provide a functionalized allene-yne-containing α-methylene butyrolactone that undergoes a Rh(I)-catalyzed cyclocarbonylation reaction to afford a 5-7-5 ring system. The resulting cycloadducts bear a structural resemblance to other NF-κB inhibitors such as cumambrin A and indeed were shown to inhibit NF-κB signaling and cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23662902      PMCID: PMC3700414          DOI: 10.1021/ol400904y

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  31 in total

Review 1.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 2.  Covalent modifiers: an orthogonal approach to drug design.

Authors:  Michele H Potashman; Mark E Duggan
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

3.  Novel chemical space exploration via natural products.

Authors:  Josefin Rosén; Johan Gottfries; Sorel Muresan; Anders Backlund; Tudor I Oprea
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

4.  NFκB inhibitors induce cell death in glioblastomas.

Authors:  Alfeu Zanotto-Filho; Elizandra Braganhol; Rafael Schröder; Luís Henrique T de Souza; Rodrigo J S Dalmolin; Matheus A Bittencourt Pasquali; Daniel Pens Gelain; Ana Maria Oliveira Battastini; José Cláudio Fonseca Moreira
Journal:  Biochem Pharmacol       Date:  2010-10-30       Impact factor: 5.858

Review 5.  Perspectives on sesquiterpene lactones in inflammation and cancer.

Authors:  Irmgard Merfort
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

6.  The exceptional chelating ability of dimethylaluminum chloride and methylaluminum dichloride. The merged stereochemical impact of alpha- and beta-stereocenters in chelate-controlled carbonyl addition reactions with enolsilane and hydride nucleophiles.

Authors:  D A Evans; B D Allison; M G Yang; C E Masse
Journal:  J Am Chem Soc       Date:  2001-11-07       Impact factor: 15.419

Review 7.  What made sesquiterpene lactones reach cancer clinical trials?

Authors:  Akram Ghantous; Hala Gali-Muhtasib; Heikki Vuorela; Najat A Saliba; Nadine Darwiche
Journal:  Drug Discov Today       Date:  2010-06-09       Impact factor: 7.851

8.  Targeted covalent drugs of the kinase family.

Authors:  Juswinder Singh; Russell C Petter; Arthur F Kluge
Journal:  Curr Opin Chem Biol       Date:  2010-07-06       Impact factor: 8.822

Review 9.  NF-kappaB and cancer-identifying targets and mechanisms.

Authors:  Willscott E Naugler; Michael Karin
Journal:  Curr Opin Genet Dev       Date:  2008-04-24       Impact factor: 5.578

10.  Tanacetum vulgare: antiherpes virus activity of crude extract and the purified compound parthenolide.

Authors:  Thelma Onozato; Celso Vataru Nakamura; Diógenes Aparício Garcia Cortez; Benedito Prado Dias Filho; Tânia Ueda-Nakamura
Journal:  Phytother Res       Date:  2009-06       Impact factor: 5.878

View more
  9 in total

1.  Allylative Approaches to the Synthesis of Complex Guaianolide Sesquiterpenes from Apiaceae and Asteraceae.

Authors:  Xirui Hu; Andrew J Musacchio; Xingyu Shen; Yujia Tao; Thomas J Maimone
Journal:  J Am Chem Soc       Date:  2019-09-06       Impact factor: 15.419

2.  A Double Allylation Strategy for Gram-Scale Guaianolide Production: Total Synthesis of (+)-Mikanokryptin.

Authors:  Xirui Hu; Silong Xu; Thomas J Maimone
Journal:  Angew Chem Int Ed Engl       Date:  2017-01-03       Impact factor: 15.336

3.  Function-Oriented and Modular (+/-)-cis-Pseudoguaianolide Synthesis: Discovery of New Nrf2 Activators and NF-κB Inhibitors.

Authors:  Fabien Emmetiere; Ranjala Ratnayake; Henry A M Schares; Katherine F M Jones; Emily Bevan-Smith; Hendrik Luesch; Daniel A Harki; Alexander J Grenning
Journal:  Chemistry       Date:  2021-02-26       Impact factor: 5.236

4.  Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues.

Authors:  Aaron M Kempema; John C Widen; Joseph K Hexum; Timothy E Andrews; Dan Wang; Susan K Rathe; Frederick A Meece; Klara E Noble; Zohar Sachs; David A Largaespada; Daniel A Harki
Journal:  Bioorg Med Chem       Date:  2015-05-30       Impact factor: 3.641

5.  Alkyne Ligation Handles: Propargylation of Hydroxyl, Sulfhydryl, Amino, and Carboxyl Groups via the Nicholas Reaction.

Authors:  Sarah M Wells; John C Widen; Daniel A Harki; Kay M Brummond
Journal:  Org Lett       Date:  2016-08-29       Impact factor: 6.005

6.  Conditions for a Rh(I)-catalyzed [2 + 2 + 1] cycloaddition reaction with methyl substituted allenes and alkynes.

Authors:  Sarah M Wells; Kay M Brummond
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

7.  Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor.

Authors:  Anand Divakaran; Siva K Talluri; Alex M Ayoub; Neeraj K Mishra; Huarui Cui; John C Widen; Norbert Berndt; Jin-Yi Zhu; Angela S Carlson; Joseph J Topczewski; Ernst K Schonbrunn; Daniel A Harki; William C K Pomerantz
Journal:  J Med Chem       Date:  2018-10-16       Impact factor: 7.446

8.  Stereoselective total synthesis of parthenolides indicates target selectivity for tubulin carboxypeptidase activity.

Authors:  Robert R A Freund; Philipp Gobrecht; Zhigang Rao; Jana Gerstmeier; Robin Schlosser; Helmar Görls; Oliver Werz; Dietmar Fischer; Hans-Dieter Arndt
Journal:  Chem Sci       Date:  2019-06-26       Impact factor: 9.825

9.  Synthesis of Guaianolide Analogues with a Tunable α-Methylene-γ-lactam Electrophile and Correlating Bioactivity with Thiol Reactivity.

Authors:  Paul A Jackson; Henry A M Schares; Katherine F M Jones; John C Widen; Daniel P Dempe; Francois Grillet; Matthew E Cuellar; Michael A Walters; Daniel A Harki; Kay M Brummond
Journal:  J Med Chem       Date:  2020-11-17       Impact factor: 7.446

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.